Tag: PFE
-
Pfizer says tornado significantly damaged warehouse storing drugs and raw materials
[ad_1] Pharmaceutical manufacturer Pfizer Inc. PFE, +1.71% said Friday that most of the damage from Wednesday’s tornado that ripped through its Rocky Mount, N.C., manufacturing facility was to a warehouse area storing finished drugs, raw materials, and packaging supplies. The 1.4 million square foot facility, which produces nearly 8% of all sterile injectable medicines used…
-
Americans say Disney is among the most patriotic brands, despite DeSantis feud
[ad_1] When it comes to the brands that Americans feel are the most patriotic, Jeep still rules the road — but Disney isn’t far behind. Jeep STLA, +0.52%, the vehicle manufacturer with an 80-plus year history and deep ties to the American military, ranked first in the annual Most Patriotic Brands in America Survey, which…
-
Most Ukraine businesses fully operational: American Chamber of Commerce in Kyiv
[ad_1] More than 480 days after Russia launched its invasion of Ukraine, 84% of the companies surveyed by the American Chamber of Commerce in Ukraine are fully operational. The survey, which was conducted jointly with member company Ernst & Young Ukraine, found that 49% of respondents reported damage to factories, facilities, storehouses or offices as a…
-
FDA advisers vote in favor of Pfizer’s maternal RSV vaccine
[ad_1] Advisers to the U.S. Food and Drug Administration voted Thursday in favor of Pfizer’s PFE, -0.73% respiratory syncytial virus vaccine for pregnant people, following extensive debate about its safety. FDA advisory-committee votes are not binding, but the agency often follows their recommendations. If the FDA ultimately approves the vaccine, called Abrysvo, it would be…
-
Merck’s $10.8 billion takeover of Prometheus gives it a foothold in immunology
[ad_1] Merck & Co.’s $10.8 billion acquisition of Prometheus Biosciences Inc., which it announced Sunday, is a strategic positive that will help the drug company diversify its portfolio and reduce the risk of an overreliance on its cancer drug Keytruda, analysts said Monday. San Diego, Calif.-based Prometheus RXDX, +69.34% is a clinical-stage biotechnology company focusing…